| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 39,453 | 35,847 | 34,810 | 37,521 | | Cost of Revenue | 4,026 | 3,955 | 3,707 | 24,282 | | | Gross Profit | 35,427 | 31,892 | 31,103 | 13,239 | | | Operating Expenses | | Research Development | 3,441 | 3,262 | 3,111 | 5,540 | | Selling General and Administrative | 26,331 | 27,334 | 26,718 | 17,507 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,655 | 1,296 | 1,274 | (9,807) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 25 | 62 | 92 | 189 | | Earnings Before Interest And Taxes | 5,680 | 1,358 | 1,366 | (9,617) | | Interest Expense | 117 | 115 | 113 |
-
| | Income Before Tax | 5,563 | 1,243 | 1,253 | (9,617) | | Income Tax Expense | 223 | 122 | 100 | 534 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,340 | 1,121 | 1,153 | (10,151) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,340 | 1,121 | 1,153 | (10,151) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,340 | $1,121 | $1,153 | ($10,151) |
|
1.52% Nasdaq 0.00%
Income Statement
